A detailed history of World Equity Group, Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, World Equity Group, Inc. holds 14,842 shares of SMMT stock, worth $324,000. This represents 0.12% of its overall portfolio holdings.

Number of Shares
14,842
Previous 12,779 16.14%
Holding current value
$324,000
Previous $99.7 Million 226.1%
% of portfolio
0.12%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$6.89 - $31.93 $14,214 - $65,871
2,063 Added 16.14%
14,842 $325 Million
Q2 2024

Jul 18, 2024

BUY
$2.39 - $10.92 $365 - $1,670
153 Added 1.21%
12,779 $99.7 Million
Q1 2024

Jul 18, 2024

BUY
$2.55 - $5.07 $32,196 - $64,013
12,626 New
12,626 $52.3 Million

Others Institutions Holding SMMT

About Summit Therapeutics Inc.


  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $4.39B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track World Equity Group, Inc. Portfolio

Follow World Equity Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on World Equity Group, Inc. with notifications on news.